KINGSTON ANNE EVANS (Chief Strategy Officer) sold 12.1% of their position (7.66K shares) of PROTHENA CORP PUBLIC LTD CO on the open market
Open‑market sale worth $64.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/31/2026ACC: 0000905148-26-003410
Officer· Chief Strategy Officer
Since Apr 2026
-11.16K
Net shares
Net seller
$94.9K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
11.16K disposed
Non-Derivative Transactions2
Ordinary Shares, par value $0.01 per share
Direct
Shares
−3.50K
Price / share
$8.56
Trade value
$29.94K
% of position
5.2%
7/28/2026
66.94K→63.44K
Ordinary Shares, par value $0.01 per share
Direct
Shares
−7.66K
Price / share
$8.47
Trade value
$64.92K
% of position
12.1%
7/29/2026
63.44K→55.78K
Total
Net shares
−11.16K
Net value
-$94.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.01 per share Direct | 7/28/2026 | F · Tax Withholding | −3.50K | $8.56 | $29.94K | 5.2% | 66.94K | 63.44K |
| Ordinary Shares, par value $0.01 per share Direct | 7/29/2026 | S · Sale | −7.66K | $8.47 | $64.92K | 12.1% | 63.44K | 55.78K |
| Total | −11.16K | -$94.86K | ||||||
Derivative Transactions0
No derivative transactions reported